# Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being Planned

> **NCT00821834** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 1003 (actual)

## Conditions studied

- Stable Angina
- Myocardial Infarction

## Interventions

- **DRUG:** clopidogrel (SR25990)
- **DRUG:** ticlopidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00821834
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 1003 (ACTUAL)
- **Last updated:** 2011-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00821834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00821834, "Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being Planned". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00821834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*